| Sector |
Chemicals
|
Compare with Sector peers |
| Industry |
Chemicals
|
Compare with Industry peers |
| Website | http://www.titanbiotechltd.com | |
| Financial Indicators | ||
|---|---|---|
| Market Cap | 312.00 Cr. | |
| Earnings per share (EPS) | 36.71 | Trailing Twelve Months Ending 2021-03 |
| Price-Earning Ratio (PE) | 10.29 | Trailing Twelve Months Ending 2021-03 |
| Industry PE | 46.88 | Trailing Twelve Months Ending 2021-03 |
| Book Value / Share | 83.21 | Trailing Twelve Months Ending 2021-03 |
| Price to Book Value | 4.54 | Calculated using Price: 377.55 |
| Dividend Yield | 0.40 | Period Ending 2020-03 |
| No. of Shares Subscribed | 0.83 Cr. | 8,263,700 Shares |
| FaceValue | 10 | |
| Company Profile | ||
|
Titan Biotech was established in 1992 with an objective of serving the scientific community and mankind by way of providing good quality of biological products i.e. protein hydrolysis, peptones and their derivatives, extracts, dehydrated microbiological culture media, plant tissue culture media and laboratory chemicals. All the biological products are basically conducive to the growth of microorganisms and their primary use is in the development and growth of microorganisms in clinical diagnosis, production of vaccines, antibiotics and antisera, antimicrobial susceptibility testing to antibiotics, checking the bacterial contamination in food & water samples in departments of microbiology and relevant fields of science in medical colleges/universities/industries and tissue culture laboratories. The company has developed more than 1700 Dehydrated Culture Media, Media Bases, and special type of Peptones and Hydrolysates for vaccine production and other uses. Titan uses the basic raw material i.e. Meet, Bile, Liver Blood, Brain, Heart and other parts of the animals in its process procured from the slaughter houses and other vegetable products like soya and casein, etc. converting them into free flowing powder to produce peptones, extracts and hydrolysates which are further used in manufacturing of dehydrated culture media and as raw material in pharmaceutical, health products and other Industries. Recently it has introduced a wide range of chromomeric / fluorogenic culture media that does not require any further identification tests. This time they are introducing a range of vegetable culture media, which are animal free and possess equivalent growth characteristics to the Culture media that use animal peptones. Besides these biological products, it also has a range of laboratory chemicals, analytical reagents, stains and indicators and Readymade stain kits. These materials are used in laboratories to carry out various tests and research work. The company also manufactures wide range of plant growth promotor and its various basic ingredients, hormones, minerals and vitamins premixes as well as amino acid in liquid, powder and granular forms. Itd product Aminofert has become very popular among the users. The basic raw materials of this product are mixtures of amino acids, minerals and vitamins. It gives complete nourishment and helps in growth and productivity. Product range of the company includes: Culture Media & Supplements
Plant Tissue Culture
Lab Chemicals & Reagents
Bulk Products
Achievements/ recognition:
|
||
Company Profile
Titan Biotech was established in 1992 with an objective of serving the scientific community and mankind by way of providing good quality of biological products i.e. protein hydrolysis, peptones and their derivatives, extracts, dehydrated microbiological culture media, plant tissue culture media and laboratory chemicals.
All the biological products are basically conducive to the growth of microorganisms and their primary use is in the development and growth of microorganisms in clinical diagnosis, production of vaccines, antibiotics and antisera, antimicrobial susceptibility testing to antibiotics, checking the bacterial contamination in food & water samples in departments of microbiology and relevant fields of science in medical colleges/universities/industries and tissue culture laboratories.
The company has developed more than 1700 Dehydrated Culture Media, Media Bases, and special type of Peptones and Hydrolysates for vaccine production and other uses. Titan uses the basic raw material i.e. Meet, Bile, Liver Blood, Brain, Heart and other parts of the animals in its process procured from the slaughter houses and other vegetable products like soya and casein, etc. converting them into free flowing powder to produce peptones, extracts and hydrolysates which are further used in manufacturing of dehydrated culture media and as raw material in pharmaceutical, health products and other Industries.
Recently it has introduced a wide range of chromomeric / fluorogenic culture media that does not require any further identification tests. This time they are introducing a range of vegetable culture media, which are animal free and possess equivalent growth characteristics to the Culture media that use animal peptones.
Besides these biological products, it also has a range of laboratory chemicals, analytical reagents, stains and indicators and Readymade stain kits. These materials are used in laboratories to carry out various tests and research work.
The company also manufactures wide range of plant growth promotor and its various basic ingredients, hormones, minerals and vitamins premixes as well as amino acid in liquid, powder and granular forms. Itd product Aminofert has become very popular among the users. The basic raw materials of this product are mixtures of amino acids, minerals and vitamins. It gives complete nourishment and helps in growth and productivity.
Product range of the company includes:
Culture Media & Supplements
Plant Tissue Culture
Lab Chemicals & Reagents
Bulk Products
Achievements/ recognition:
| 1 Day |
|
-1.72% |
| 1 Week |
|
-4.56% |
| 1 Month |
|
+10.20% |
| 3 Month |
|
+16.74% |
| 6 Month |
|
+122.68% |
| 1 Year |
|
+321.14% |
| 2 Year |
|
+920.41% |
| 5 Year |
|
+934.38% |
| 6 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | |
| Return on Equity (%) | 7.97 | 8.42 | 9.80 | 11.27 | 13.84 | 21.97 | |
| Return on Capital Employed (%) | 12.21 | 12.06 | 12.32 | 13.59 | 14.88 | 21.45 | |
| Return on Assets (%) | 4.87 | 4.81 | 4.73 | 4.85 | 6.32 | 10.89 |
| Particulars | 6 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Shh. Funds | 20 | 22 | 23 | 24 | 32 | 39 | |
| Non Curr. Liab. | 3 | 5 | 16 | 20 | 15 | 14 | |
| Curr. Liab. | 10 | 13 | 12 | 12 | 17 | 22 | |
| Minority Int. | 1 | 1 | 1 | 2 | 2 | ||
| Equity & Liab. | 34 | 40 | 52 | 58 | 66 | 78 | |
| Non Curr. Assets | 12 | 16 | 23 | 28 | 30 | 32 | |
| Curr. Assets | 21 | 24 | 30 | 30 | 36 | 46 | |
| Misc. Exp. not W/O | 0 | 0 | 0 | 0 | |||
| Total Assets | 34 | 40 | 52 | 58 | 66 | 78 |
| Particulars | 6 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Net Sales | 40 | 46 | 53 | 57 | 65 | 79 | |
| Other Income | 0 | 1 | 0 | 0 | 1 | 0 | |
| Total Income | 41 | 46 | 53 | 58 | 66 | 80 | |
| Total Expenditure | -36 | -42 | -47 | -50 | -56 | -66 | |
| PBIDT | 4 | 4 | 6 | 7 | 10 | 14 | |
| Interest | -1 | -1 | -1 | -2 | -2 | -2 | |
| Depreciation | -1 | -1 | -1 | -1 | -2 | -2 | |
| Taxation | -1 | -1 | -1 | -1 | -2 | -3 | |
| Exceptional Items | 1 | ||||||
| PAT | 2 | 2 | 2 | 3 | 4 | 8 |
| Particulars | 6 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Cash Fr. Operatn. | -2 | 5 | 0 | 2 | 5 | 6 | |
| Cash Fr. Inv. | -3 | -5 | -8 | -6 | -4 | -2 | |
| Cash Fr. Finan. | 3 | 2 | 9 | 0 | 0 | -4 | |
| Net Change | -2 | 2 | 1 | -3 | 1 | 0 | |
| Cash & Cash Eqvt | 0 | 4 | 4 | 1 | 2 | 2 |
|
Sat, 31 Jul 2021
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation for loss of shares/request for duplicate issue of shares. |
|
Sat, 31 Jul 2021
Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper publcation of Date of Board Meeting for considering unudited quarterly financial results of company for quarter ended 30th June 2021. |
|
Fri, 30 Jul 2021
Board Meeting Intimation for Considering Unaudited Financial Results For Quarter Ended 30Th June 2021. TITAN BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2021 inter alia to consider and approve Unaudited Financial Results for quarter ended 30th June 2021. |
| Thu, 05 Aug 2021 |
Closing Below Previous Low
|
Close Within 52 Week High Zone
|
| Wed, 04 Aug 2021 |
High Delivery Percentage
|
|
Close Within 52 Week High Zone
|
CCI Bearish
|
Equities
M.F.
Sectors